11:33 AM EST - Zomedica Pharmaceuticals Corp. : Announced a development update on the Company's four therapeutic candidates for use in companion animals, namely dogs and cats. Zomedica Pharmaceuticals Corp.
shares V.ZOM are trading down $0.06 at $2.90.
